首页 > 市场调查报告书 > 製药

疫苗感染疾病

2030 年亚太地区疟疾治疗市场预测 - 区域分析 - 按治疗、给药途径和配销通路

市场调查报告书

商品编码

1510756

2030 年亚太地区疟疾治疗市场预测 - 区域分析 - 按治疗、给药途径和配销通路

Asia Pacific Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 88 Pages | 订单完成后即时交付

价格

简介目录图表

2022年亚太地区疟疾治疗市值为6.3137亿美元，预计2030年将达到51.7915亿美元；预计2022年至2030年复合年增长率为30.1%。

市场参与者不断增加的策略性措施推动亚太疟疾治疗市场

疟疾治疗市场的一些主要参与者越来越注重采用各种策略，例如产品创新、发布和批准；研发投资；以及併购以保持竞争力。下面提到了其中一些措施：

2023年，R21/Matrix-M疟疾疫苗被纳入世界卫生组织的预审疫苗清单。根据疟疾政策咨询小组和世卫组织免疫策略咨询专家小组 (SAGE) 的建议，世卫组织建议于 2023 年 10 月引入免疫接种，以预防儿童疟疾。资格预审是联合国儿童基金会购买疫苗以及全球疫苗免疫联盟为其部署提供财政支持的要求，这意味着更多的儿童将获得疫苗作为对抗疟疾的重要工具。

2022 年3 月，用于治疗特定疟疾菌株的新药他非诺喹在澳洲获得了Medicines for Malaria Venture (MMV) 的许可，该公司与葛兰素史克(GSK) 共同开发了该药物，用于儿童和青少年。该药与广泛使用的抗疟药－氯奎联合使用。

2021年12月，Zydus Cadila宣布计画与Medicines for Malaria Venture合作开发其抗疟药物ZY19489，并获得美国FDA批准。据该公司称，ZY19489的I期试验证明了其半衰期长，并且具有单剂量治癒疟疾的潜力。在一项单独的疟疾挑战试验中，单次口服 ZY19489 后显示出强烈的抗疟活性。

2021年1月，GSK、PATH和Bharat Biotech (BBIL)宣布签署疟疾疫苗RTS,S/AS01E的产品转移协议。该协议包括将疫苗 RTS,S 抗原部分的生产转移给 BBIL，并向 BBIL 授予与疟疾疫苗相关的所有权利的许可。 GSK 保留疫苗佐剂（AS01E）的生产并供应给 BBIL。

因此，市场参与者的上述策略性倡议预计将为未来几年的疟疾治疗市场提供成长机会。

亚太地区疟疾治疗市场概况

马来西亚、印尼、纽西兰、越南、菲律宾、新加坡和泰国是亚太其他地区的主要国家。其中大多数是低收入和中等收入国家，医疗保健支出较高。根据美国国家传染病中心 2022 年报告，新加坡每年约有 100-300 例疟疾病例（80% 间日疟）是输入性的。总部位于新加坡区域中心的联合秘书处促进 APLMA 和亚太消除疟疾网路 (APMEN) 之间的跨境合作，透过量身定制的解决方案消除亚太地区的疟疾。

全球健康组织的报告指出，马来西亚近三分之一（32%）的疟疾病例发生在马来西亚半岛，其中大部分发生在中部、东南部和北部沿海地区。例如，年轻的职业男性感染疟疾的风险很高，据报道，近 50% 被诊断出患有疟疾的马来西亚人从事农业和其他户外工作。该计划包括对疑似疟疾病例进行 100% 确证检测、对发现的病例进行强制报告、综合病媒管理和社区参与，并挑选一批志愿初级卫生保健人员并接受疟疾诊断和治疗方面的培训。此外，马来西亚是 APMEN 的国家合作伙伴，该网路由 18 个亚太国家和其他利益相关者组成，致力于消除该国的疟疾。

因此，上述因素将促进该地区疟疾治疗市场的成长。

亚太地区疟疾治疗市场收入及 2030 年预测（百万美元）

亚太地区疟疾治疗市场区隔

亚太地区疟疾治疗市场根据治疗、给药途径、配销通路和国家进行细分。根据治疗方法，亚太地区疟疾治疗市场分为仿製药、原厂药、疫苗等。 2022 年，疫苗领域占据最大的市场。

就给药途径而言，亚太地区疟疾治疗市场分为口服和肠外给药。 2022年，口腔细分市场占据了更大的市场。

依配销通路，亚太疟疾治疗市场分为直接招标、医院药局、零售药局、线上药局等。 2022 年，直接招标领域占据最大的市场份额。

依国家/地区划分，亚太地区疟疾治疗市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022 年，亚太地区其他地区主导了亚太地区疟疾治疗市场。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、赛诺菲 SA、GSK Plc、诺华 AG、辉瑞 Inc、AdvaCare Pharma USA LLC 和 Lupin Ltd 是亚太地区疟疾治疗市场的一些领先参与者。

A few major players operating in the malaria treatment market are increasingly focusing on the adoption of various strategies such as product innovations, launches, and approvals; R&D investments; and mergers and acquisitions in order to remain competitive. A few of these initiatives are mentioned below:

In 2023, The R21/Matrix-M malaria vaccine is included in the WHO's list of prequalified vaccines. Following the recommendations of the Malaria Policy Advisory Group and the WHO Strategic Advisory Group of Experts (SAGE) on Immunization, the WHO recommended its introduction in October 2023 to prevent malaria in children. Prequalification is a requirement for UNICEF to purchase vaccinations and for Gavi, the Vaccine Alliance, to provide financial support for their deployment, which means that more children will have access to vaccines as a crucial tool in the fight against malaria.

In March 2022, tafenoquine, a novel drug used to treat a specific strain of malaria, was licensed in Australia by Medicines for Malaria Venture (MMV), which codeveloped the drug with GlaxoSmithKline (GSK) for children and adolescents. The drug is combined with the widely used antimalarial drug-chloroquine.

In December 2021, Zydus Cadila announced the plan to develop its antimalarial drug ZY19489 with Medicines for Malaria Venture, which received US FDA approval. According to the company, the Phase I trial of ZY19489 demonstrated a long half-life and the potential for a single-dose cure for malaria. In a separate malaria challenge trial, strong antimalarial activity was displayed after a single oral dose of ZY19489.

In January 2021, GSK, PATH, and Bharat Biotech (BBIL) declared that a product transfer agreement was signed for the malaria vaccine RTS,S/AS01E. The agreement included transferring the manufacturing of the RTS,S antigen portion of the vaccine and granting a license for all rights related to the malaria vaccine to BBIL. GSK retains production of the vaccine adjuvant (AS01E) and supplies it to BBIL.

Therefore, the abovementioned strategic initiatives by the market players are expected to provide growth opportunities for the malaria treatment market in the coming years.

Asia Pacific Malaria Treatment Market Overview

Malaysia, Indonesia, New Zealand, Vietnam, the Philippines, Singapore, and Thailand are among the major countries in the Rest of Asia Pacific. Most of these are low- and middle-income countries, with high healthcare expenditures. According to the National Centre for Infectious Diseases 2022 report, ~100-300 malaria cases (80% vivax) per annum are imported in Singapore. A joint secretariat headquartered in the regional hub of Singapore facilitates a cross-border collaboration between APLMA and Asia Pacific Malaria Elimination Network (APMEN) to eliminate malaria from Asia Pacific with tailored solutions.

The Global Health Group report states that nearly one-third (32%) of total malaria cases in Malaysia occur in Peninsula Malaysia, and the majority of these are found in the Central, Southeastern, and northern coastal regions. For example, young working males are at high risk of getting infected with malaria, and nearly 50% of Malaysians diagnosed with malaria reportedly work in agriculture and other outdoor jobs. The program includes 100% confirmatory testing of suspected malaria cases, mandatory reporting of detected cases, integrated vector management, and string community participation, with a cadre of volunteer primary healthcare workers selected and trained in malaria diagnosis and treatment. Further, Malaysia is a country partner of the APMEN, a network composed of 18 Asia Pacific countries and other stakeholders working to eliminate malaria in the country.

Thus, the abovementioned factors will foster the growth of the malaria treatment market in this region.

Asia Pacific Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Malaria Treatment Market Segmentation

The Asia Pacific malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Asia Pacific malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The vaccines segment held the largest market share in 2022.

In terms of route of administration, the Asia Pacific malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the Asia Pacific malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the Asia Pacific malaria treatment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Rest of Asia Pacific dominated the Asia Pacific malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, and Lupin Ltd are some of the leading players operating in the Asia Pacific malaria treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Malaria Treatment Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Malaria
- 4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
- 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
- 4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis

5. Malaria Treatment Market - Asia Pacific Market Analysis

5.1 Asia Pacific Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 Asia Pacific Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
- 6.3.1 Overview
- 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
- 6.4.1 Overview
- 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
- 6.5.1 Overview
- 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. Asia Pacific Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

7.1 Overview
7.2 Asia Pacific Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
- 7.3.1 Overview
- 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
- 7.4.1 Overview
- 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 Asia Pacific Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
- 8.3.1 Overview
- 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
- 8.4.1 Overview
- 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Retail Pharmacies
- 8.5.1 Overview
- 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Online Pharmacies
- 8.6.1 Overview
- 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Malaria Treatment Market - Country Analysis

9.1 Asia Pacific Malaria Treatment Market, Revenue and Forecast to 2030
- 9.1.1 Overview
  - 9.1.1.1 Asia Pacific: Malaria Treatment Market, by Countries
  - 9.1.1.2 Japan
  - 9.1.1.3 Overview
    - 9.1.1.3.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 Japan: Malaria Treatment Market, by Treatment
    - 9.1.1.3.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.3.4 Japan: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.3.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.3.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.4 India
  - 9.1.1.5 Overview
    - 9.1.1.5.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 India: Malaria Treatment Market, by Treatment
    - 9.1.1.5.3 India: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.5.4 India: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.5.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.5.4.2 India: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.6 South Korea
  - 9.1.1.7 Overview
    - 9.1.1.7.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 South Korea: Malaria Treatment Market, by Treatment
    - 9.1.1.7.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.7.4 South Korea: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.7.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.7.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.8 Australia
  - 9.1.1.9 Overview
    - 9.1.1.9.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.9.2 Australia: Malaria Treatment Market, by Treatment
    - 9.1.1.9.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.9.4 Australia: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.9.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.9.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.10 Rest of Asia Pacific
  - 9.1.1.11 Overview
    - 9.1.1.11.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.11.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
    - 9.1.1.11.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.11.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.11.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.11.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 GSK Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Service
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 AdvaCare Pharma USA LLC
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Lupin Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 5. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 21. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 22. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 23. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 24. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 25. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 26. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 27. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 28. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 29. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 30. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 31. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 32. Glossary of Terms, Malaria Treatment Market

List Of Figures

Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. Asia Pacific Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Asia Pacific Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Malaria Treatment Market, 2022 ($Mn)
Figure 19. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the Malaria Treatment Market